Keith C. Kummerfeld files SEC Form 4 disclosures for Arcturus Therapeutics Holdings Inc.. They have made 4 open-market trades across 1 company since 2019, most recently 2023-07-14.
CIK 0001762749
2 open-market purchases totalling $20K since 2019, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARCT | 6,887 | $71K |
Shares reported on the most recent Form 4, priced at the 2023-07-18 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.